Status:
ENROLLING_BY_INVITATION
Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Pancreatic
Eligibility:
All Genders
18-80 years
Brief Summary
This is an observational study of patients diagnosed with pancreatic cancer by pathology, with a control group of patients with pathology suggestive of benign pancreatic lesions and normal subjects, a...
Eligibility Criteria
Inclusion
- Diagnosis of pancreatic cancer confirmed by imaging (case) Diagnosis of chronic pancreatitis confirmed by imaging (hospital control)
Exclusion
- The pathology diagnosis and imaging does not matched Patients with other malignant tumors Patients with other severe systemic diseases
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06108531
Start Date
November 1 2023
End Date
August 1 2026
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, School of Medicine
Shanghai, Shanghai Municipality, China, 20092